429 related articles for article (PubMed ID: 31828134)
1. Therapeutic Strategies for Attenuation of Retinal Ganglion Cell Injury in Optic Neuropathies: Concepts in Translational Research and Therapeutic Implications.
Fu L; Kwok SS; Chan YK; Ming Lai JS; Pan W; Nie L; Shih KC
Biomed Res Int; 2019; 2019():8397521. PubMed ID: 31828134
[TBL] [Abstract][Full Text] [Related]
2. Emerging Mitochondrial Therapeutic Targets in Optic Neuropathies.
Lopez Sanchez MI; Crowston JG; Mackey DA; Trounce IA
Pharmacol Ther; 2016 Sep; 165():132-52. PubMed ID: 27288727
[TBL] [Abstract][Full Text] [Related]
3. Progress in Gene Therapy to Prevent Retinal Ganglion Cell Loss in Glaucoma and Leber's Hereditary Optic Neuropathy.
Ratican SE; Osborne A; Martin KR
Neural Plast; 2018; 2018():7108948. PubMed ID: 29853847
[TBL] [Abstract][Full Text] [Related]
4. Protecting retinal ganglion cells.
Khatib TZ; Martin KR
Eye (Lond); 2017 Feb; 31(2):218-224. PubMed ID: 28085136
[TBL] [Abstract][Full Text] [Related]
5. Protection of retinal ganglion cells in glaucoma: Current status and future.
Shen J; Wang Y; Yao K
Exp Eye Res; 2021 Apr; 205():108506. PubMed ID: 33609512
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy for optic nerve disease.
Martin KR; Quigley HA
Eye (Lond); 2004 Nov; 18(11):1049-55. PubMed ID: 15534589
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial Membrane Dynamics and Inherited Optic Neuropathies.
Bagli E; Zikou AK; Agnantis N; Kitsos G
In Vivo; 2017; 31(4):511-525. PubMed ID: 28652416
[TBL] [Abstract][Full Text] [Related]
8. Characterization of intravitreally delivered capsid mutant AAV2-Cre vector to induce tissue-specific mutations in murine retinal ganglion cells.
Langouet-Astrie CJ; Yang Z; Polisetti SM; Welsbie DS; Hauswirth WW; Zack DJ; Merbs SL; Enke RA
Exp Eye Res; 2016 Oct; 151():61-7. PubMed ID: 27481653
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotection in Glaucoma: Animal Models and Clinical Trials.
Almasieh M; Levin LA
Annu Rev Vis Sci; 2017 Sep; 3():91-120. PubMed ID: 28731838
[TBL] [Abstract][Full Text] [Related]
10. A Review of Mitochondrial Optic Neuropathies: From Inherited to Acquired Forms.
Pilz YL; Bass SJ; Sherman J
J Optom; 2017; 10(4):205-214. PubMed ID: 28040497
[TBL] [Abstract][Full Text] [Related]
11. An agonistic TrkB mAb causes sustained TrkB activation, delays RGC death, and protects the retinal structure in optic nerve axotomy and in glaucoma.
Bai Y; Xu J; Brahimi F; Zhuo Y; Sarunic MV; Saragovi HU
Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4722-31. PubMed ID: 20357199
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy in optic nerve disease.
DeBusk A; Moster ML
Curr Opin Ophthalmol; 2018 May; 29(3):234-238. PubMed ID: 29538182
[TBL] [Abstract][Full Text] [Related]
13. Molecular and cell-based approaches for neuroprotection in glaucoma.
Lebrun-Julien F; Di Polo A
Optom Vis Sci; 2008 Jun; 85(6):417-24. PubMed ID: 18521011
[TBL] [Abstract][Full Text] [Related]
14. Strategies for optic nerve rescue and regeneration in glaucoma and other optic neuropathies.
Dahlmann-Noor AH; Vijay S; Limb GA; Khaw PT
Drug Discov Today; 2010 Apr; 15(7-8):287-99. PubMed ID: 20197108
[TBL] [Abstract][Full Text] [Related]
15. Adeno-associated virus mediated gene therapy for neuroprotection of retinal ganglion cells in glaucoma.
Starr C; Chen B
Vision Res; 2023 May; 206():108196. PubMed ID: 36812679
[TBL] [Abstract][Full Text] [Related]
16. Direct and indirect approaches to neuroprotective therapy of glaucomatous optic neuropathy.
Levin LA
Surv Ophthalmol; 1999 Jun; 43 Suppl 1():S98-101. PubMed ID: 10416753
[TBL] [Abstract][Full Text] [Related]
17. Induced Pluripotent Stem Cells for Inherited Optic Neuropathies-Disease Modeling and Therapeutic Development.
Harvey JP; Sladen PE; Yu-Wai-Man P; Cheetham ME
J Neuroophthalmol; 2022 Mar; 42(1):35-44. PubMed ID: 34629400
[TBL] [Abstract][Full Text] [Related]
18. Genetically determined optic neuropathies.
Milea D; Amati-Bonneau P; Reynier P; Bonneau D
Curr Opin Neurol; 2010 Feb; 23(1):24-8. PubMed ID: 19915464
[TBL] [Abstract][Full Text] [Related]
19. Axonal loss and neuroprotection in optic neuropathies.
Levin LA
Can J Ophthalmol; 2007 Jun; 42(3):403-8. PubMed ID: 17508035
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic strategies for glaucoma and optic neuropathies.
Lo J; Mehta K; Dhillon A; Huang YK; Luo Z; Nam MH; Al Diri I; Chang KC
Mol Aspects Med; 2023 Dec; 94():101219. PubMed ID: 37839232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
